ACTG A5079 PHYSIOLOGIC TESTOSTERONE SUPPLEMENTATION IN HIV

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Test the hypothesis that the change in visceral fat cross-sectional area from baseline to 24 weeks will be greater with testosterone replacement than with placebo in HIV-positive men with abdominal obesity who have mildly to moderately reduced serum testosterone levels. Evaluate the safety and tolerability of this treatment. Evaluate the effect of testosterone replacement on lipid metabolism. Assess regional fat by DEXA and CT. Evaluate the effect of testosterone replacement on lean body mass. Evaluate the effect on waist-to-hip ratio and abdominal circumfrance, evaluate effect on quality of life and body image, and evaluate the 48 week durability of the effect of testosterone replacement.